EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Off-Label Prescribing in Pediatric Population—Literature Review for 2012–2022

Valentina Petkova iD, Dilyana Georgieva iD, Milen Dimitrov iD, Irina Nikolova

Pharmaceutics · 21.11.2023 · 15 (12) · 2652

DOI: 10.3390/pharmaceutics15122652 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 21.11.2023. Verfasst von Valentina Petkova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social Pharmacy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Off-label prescribing is widespread among pediatricians, and it is unlikely that this trend will soon be bound by a uniform legal framework. This is necessitated by the fact that there are four variables: the patient’s health condition, the physician’s experience and knowledge, the legislative measures (laws, directives, guidelines, and recommendations), and finally, the pharmaceutical industry. There is considerable concern worldwide about the use of off-label medicines in children. We may call it an enormous global problem that is much talked about and written about; however, we should not forget that the goal around which everyone should unite is the patient’s life. For healthcare providers, the most important thing will always be the health and preservation of the patient’s life, particularly when it comes to children with life-threatening conditions in neonatal and pediatric intensive care units (NICU and PICU). The study aimed to examine the prevalence of off-label drug use in pediatrics. Literature research was conducted, and we included studies from 2012 to 2022 that evaluated off-label drug prevalence in various pediatric patient populations.

Schlagwörter

Stichwörter der Autor:innen

childrenlegislationneonatesoff-label usepediatricsprescriptionsafety

Autor:innen und Institutionen

  • Department of Social Pharmacy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
  • Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.

ORCID-Profile: Valentina Petkova, Dilyana Georgieva, Milen Dimitrov

Förderung

  • European Union-NextGenerationEU

Zitieren

APA

Petkova, V., Georgieva, D., Dimitrov, M., & Nikolova, I. (2023). Off-Label Prescribing in Pediatric Population—Literature Review for 2012–2022. Pharmaceutics, 15(12), 2652. https://doi.org/10.3390/pharmaceutics15122652

Vancouver

Petkova V, Georgieva D, Dimitrov M, Nikolova I. Off-Label Prescribing in Pediatric Population—Literature Review for 2012–2022. Pharmaceutics. 2023;15(12):2652. doi:10.3390/pharmaceutics15122652

BibTeX
@article{Petkova2023,
  author = {Petkova, Valentina and Georgieva, Dilyana and Dimitrov, Milen and Nikolova, Irina},
  title = {Off-Label Prescribing in Pediatric Population—Literature Review for 2012–2022},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {12},
  pages = {2652},
  doi = {10.3390/pharmaceutics15122652}
}
Kostenlos starten →